Serpine

Quick links to important sections

Serpine

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serpine

Property Description
Active ingredient Hydralazine hydrochloride
Form Oral tablet
Pharmacological class Antihypertensive agent; Direct-acting peripheral vasodilator
Common use Managing high blood pressure
Origin Synthetic compound

Serpine is a synthetic prescription medicine whose active component is Hydralazine hydrochloride, belonging to the major pharmacological group of antihypertensive agents. It is specifically classified as a direct-acting peripheral vasodilator and is chemically derived from the phthalazine structure, a unique chemical designation that has been clinically recognized for its potent vascular effects. This medicine is a single-ingredient product, confirming that its therapeutic effect stems solely from the presence of the Hydralazine molecule.


What Type of Medicine Is Serpine?

Serpine is an antihypertensive agent used to reduce high blood pressure. It achieves this goal through its unique classification as a direct-acting peripheral vasodilator, a mechanism defined by its action on the small resistance blood vessels. Hydralazine has been extensively used as an antihypertensive medication due to its ability to directly induce relaxation of vascular smooth muscle. This specific mechanism provides a key differentiation from agents that modulate neurohormonal pathways. Serpine is exclusively a prescription medicine, reflecting the need for medical supervision due to its systemic effects.


Serpine's Active Ingredient and Form

The active ingredient in Serpine is Hydralazine hydrochloride (INN: Hydralazine), and the drug is primarily available as an oral tablet formulation for oral administration. This presentation provides a convenient, non-invasive method for drug delivery, supporting long-term use. The drug functions by causing the blood vessels to relax. The tablet itself consists of the active Hydralazine compound combined with solid excipients—inert substances necessary to form the preparation—ensuring the correct dose is delivered consistently.


The General Purpose of This Vasodilator

The general purpose of Serpine is to support the circulatory system by acting as a powerful vascular relaxant to decrease systemic vascular resistance. By causing the resistance arterioles to relax and widen, Serpine directly facilitates smoother blood flow. This vasodilating effect fundamentally eases the effort required by the heart to circulate blood, resulting in the primary therapeutic benefit of lowering and maintaining balanced blood pressure levels, a typical use scenario for this class of medication.

Regulatory References

  1. (MedlinePlus, Hydralazine)

What side effects are possible with Serpine?

Possible side effects and safety information for Serpine

The official regulatory profile for Serpine (Hydralazine) outlines adverse effects classified by frequency and the body systems they impact. The most frequently documented adverse reactions, classified as Common (1% to 10%), are primarily cardiovascular and neurological, including palpitations, tachycardia, headache, flushing, and hypotension. Gastrointestinal effects like nausea and vomiting are also categorized as common.


Systemic and Serious Reactions

The medicine is associated with a risk of Serious Adverse Reactions, which are less frequent but clinically significant. These include blood dyscrasias (such as leukopenia and agranulocytosis), hepatitis, and, importantly, the potential for a Systemic Lupus Erythematosus-like syndrome. This immune-related reaction is specifically linked to prolonged exposure, typically observed after six months of therapy and often with higher daily doses. Conversely, common effects like headache and tachycardia are generally noted as being more likely at the start of treatment or during rapid dose changes.


Safety Considerations and Restrictions

Official labels detail restrictions on use, including contraindications for individuals with pre-existing conditions like Idiopathic Systemic Lupus Erythematosus (SLE) and certain types of Coronary Artery Disease. Population-specific safety statements apply to groups such as slow acetylators and women, who are noted to have a higher risk of developing the SLE-like syndrome. Furthermore, consideration for dosing adjustment is advised for patients with severe renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define Serpine (Hydralazine) overdose based on manifestations of profound vasodilation and subsequent cardiovascular instability. Immediate medical attention must be sought upon any suspicion of overdose.

Documented Overdose Manifestations

Classification Official Regulatory Statement
Common Signs Hypotension, tachycardia, headache, and generalized skin flushing.
Severe Outcomes Profound shock, myocardial ischemia, subsequent myocardial infarction, and cardiac arrhythmia.

Emergency Actions and Management

If an overdose is suspected, official guidance mandates immediately contacting a Poison Control Center or emergency services. The primary goal of treatment is the support of the cardiovascular system, as no specific antidote is known for Hydralazine overdose.

Regulatory management protocols include treating shock with plasma expanders and managing severe tachycardia with beta blockers. When necessary, the administration of vasopressors requires extreme caution to avoid precipitating or aggravating cardiac arrhythmia. The potential for these life-threatening events underscores the need for immediate clinical intervention.

Therapeutic Uses of Serpine

Quick Facts

  • Main Uses: Treatment of elevated blood pressure (hypertension). Historically used for managing severe emotional distress in patients with specific mental health conditions.

Serpine: Approved Uses

Serpine is indicated for the treatment of elevated blood pressure (hypertension). The primary therapeutic purpose is to aid in the reduction of high blood pressure, which is a common health condition that can negatively impact the brain, heart, blood vessels, and kidneys if left unmanaged. By working to regulate the nervous system's activity, the compound helps to relax the blood vessels and reduce the force of the heartbeat.

Historically, Serpine was also utilized for the management of severe agitation in individuals experiencing certain mental health conditions. While still recognized for this effect, its clinical use for this purpose is now limited due to the availability of other treatments.

Benefits of Therapy

The primary benefit of Serpine therapy in individuals with high blood pressure is the reduction of blood pressure levels, which helps to manage the risks associated with this condition, such as heart failure, stroke, and kidney issues. Continuation of therapy, as directed by a healthcare professional, is necessary to maintain this pressure regulation.

Eligibility and Restrictions for Use

Who Can and Cannot Use Serpine?


The population eligibility for Serpine (Hydralazine) is strictly defined by official regulatory documentation, outlining groups for whom use is permitted, restricted, or absolutely prohibited.

Contraindications and Prohibited Use

Serpine is contraindicated (must not be used) in patients with pre-existing conditions explicitly listed in official labeling. These absolute non-eligibility conditions include a known hypersensitivity to hydralazine, and specific severe cardiac issues such as Coronary Artery Disease (CAD), Mitral Valvular Rheumatic Heart Disease, and certain forms of Myocardial Insufficiency due to mechanical obstruction. Use is also prohibited in patients with Idiopathic Systemic Lupus Erythematosus (SLE).

Age and Health Limitations

Use is not recommended for pediatric patients as safety and effectiveness have not been established in controlled clinical trials. In patients with renal impairment (kidney damage) or hepatic dysfunction (liver disease), Serpine may be used, but only under conditional caution, as the dose or dosing interval often requires adaptation to prevent drug accumulation.

Pregnancy and Lactation Status

During pregnancy, Serpine is classified for conditional use and is generally reserved for treating severe hypertension (e.g., pre-eclampsia) primarily in the third trimester when the maternal or fetal benefit outweighs potential risk. The medicine is excreted in breast milk, and use during lactation requires caution and monitoring of the infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Serpine (Hydralazine) describes interactions primarily based on pharmacodynamic potentiation and pharmacokinetic exposure changes.

Interaction Type Interacting Substances Official Description/Restriction
Pharmacodynamic Other Antihypertensives, Anesthetics, Nitrates, Tricyclic Antidepressants, Alcohol Co-administration enhances the hypotensive effects (additive blood pressure lowering).
Exposure Altering Food Administration with food results in higher plasma levels (increased systemic exposure) of Serpine.
Pharmacokinetic Certain Beta-blockers May increase the bioavailability and therefore the exposure of the co-administered beta-blocker.

Co-administration with potent parenteral antihypertensive drugs, such as Diazoxide, carries a documented risk of marked hypotension and requires continuous patient observation for several hours. The use of Adrenaline (Epinephrine) to correct severe hypotension in Serpine-treated patients is restricted as it is officially documented to enhance the cardiac-accelerating effects of Serpine.

Serpine exposure is subject to polymorphic acetylation; regulatory documents note that individuals classified as slow acetylators generally exhibit higher plasma concentrations. Additionally, MAO inhibitors should be used with regulatory caution, and the hypotensive effect may be antagonized by co-administration with NSAIDs or Oestrogens.

Mechanism of Action

Serpine (Hydralazine) is a direct-acting agent that affects vascular resistance by modulating the function of smooth muscle cells in arterioles.

Modulating Intracellular Calcium for Smooth Muscle Relaxation

This action begins inside the cellular environment with the drug's interference with the release of calcium ions ( Ca^2+). The drug inhibits the IP3 receptors on the internal storage sites (Sarcoplasmic Reticulum) of the vascular smooth muscle cells. This blockade halts the calcium-driven cascade that activates muscle contraction, resulting in the relaxation and vasodilation of the resistance blood vessels.

Reduction of Systemic Vascular Resistance

This mechanism dictates the systemic consequence of the cellular action. The widening of arterioles reduces the overall impedance to blood flow, resulting in a reduction of Systemic Vascular Resistance ( SVR). This reduction in SVR represents the primary physiological change resulting from the drug's mechanism on the circulation.

Activation of Compensatory Physiological Reflexes

While the drug’s primary mechanism is peripheral vasodilation, the resulting physiological change triggers the body's baroreceptor reflex. This reflexive action increases the activity of the sympathetic nervous system, leading to compensatory effects, such as an increase in heart rate and cardiac output. This physiological response counteracts the mechanism's primary vasodilatory effect.

Dosage and Administration Information

Serpine is administered through two primary, officially approved routes: the oral tablet for chronic, long-term use, and intravenous (IV) or intramuscular (IM) injection for urgent, short-term use in a supervised clinical setting.

The initiation of oral therapy is governed by a mandated stepwise titration process. Treatment begins with a low dose, such as 10 mg four times daily or 25 mg twice daily, and is gradually increased over several weeks, maintaining a schedule of two to four divided doses daily. The maximum recommended dose for chronic use is generally 200 mg/day in certain jurisdictions. The oral tablet must be taken consistently with food to optimize drug absorption and consistency.

Official instructions define necessary dose modifications for certain patient populations. The dose or dosing interval must be adapted for individuals with renal or hepatic impairment to avoid drug accumulation. Additionally, the maximum daily dose may be limited for individuals whose metabolic profile affects drug clearance. If a dose is missed, it is advised to take it as soon as possible, but doubling the dose to compensate is strictly prohibited. The injectable form is reserved only for situations where the oral route is not feasible, and patients are to be transferred to the oral formulation as soon as their condition allows.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Summary

The available research has explored a non-opioid approach for managing chronic pain. Studies have examined the drug's pharmacology and the outcomes of interest in various pain conditions.

The drug's pharmacology has been studied.

Key Study Findings

Studies measured the change in certain types of chronic pain, particularly neuropathic pain and chronic low back pain. Clinical trials examined patients over a 12-week period, with observed data on changes to average daily pain scores compared to placebo.

Trials examined the drug's impact on the severity and frequency of pain episodes. Initial clinical trials investigated the drug; long-term data were not available from the initial trials.

  • Research investigated the effect on acute pain episodes.

Dosage and Administration Studies

Research has explored various dosing strategies. Dosing methodologies used in studies included a stepped approach.

  • Administration frequency was investigated as twice daily.

Interaction and Safety Profile

Research has explored the potential for interactions when combining the drug with certain Selective Serotonin Reuptake Inhibitors (SSRIs) and Monoamine Oxidase Inhibitors (MAOIs), due to the potential for side effects.

Studies included participants who did not have pre-existing heart conditions. Data on this population were not available. Safety studies reported dry mouth, nausea, and somnolence as frequently occurring effects.

Frequently Asked Questions (FAQ)

Common questions about Serpine (FAQ)

Q: Is Serpine a short-term or long-term treatment?

A: Serpine is available in two forms for different treatment durations. Official guidance indicates the oral tablet is intended for chronic, long-term use in managing high blood pressure. The injectable form (IV or IM) is reserved for urgent, short-term use in supervised clinical settings.

Q: Can Serpine make you feel tired or drowsy?

A: Yes, official patient information for Serpine lists both unusual tiredness or weakness (fatigue) and drowsiness as potential side effects. These are typically categorized as less frequent side effects. If these effects are experienced, regulatory information suggests caution may be warranted when performing activities like driving or operating machinery.

Q: What are the most serious, but rare, side effects of Serpine?

A: Serious adverse reactions are outlined in official safety profiles and are typically categorized as uncommon (less than 1%) or rare. These include the potential for blood dyscrasias (severe blood disorders) and rare cases of hepatitis (liver inflammation). The drug is also associated with a risk of developing a Systemic Lupus Erythematosus-like syndrome with prolonged use.

Q: Is it common to have mild nausea when first starting Serpine?

A: Yes, nausea is listed in regulatory documents as a common gastrointestinal side effect, reported by 1% to 10% of users. Official information notes that common effects, such as headaches and a rapid heart rate, are often reported at the start of treatment or during dose adjustments.

Q: Are there any dietary restrictions or foods to avoid while on Serpine?

A: Official regulatory information does not list any specific food restrictions to avoid while taking Serpine. However, regulatory instructions state the oral tablet should be taken consistently with food to optimize drug absorption and consistent exposure.

Q: Is it normal to experience vivid dreams or sleep changes on Serpine?

A: Yes, official patient information documents indicate that changes in sleep patterns can occur. Less common side effects reported with Serpine include both vivid dreams and issues like early-morning sleeplessness (insomnia).

Q: What is the most important thing to tell my doctor before starting Serpine?

A: Official regulatory documents indicate that conditions such as a history of Coronary Artery Disease (CAD), Systemic Lupus Erythematosus (SLE), or known hypersensitivity to the drug should be discussed before starting therapy. These conditions are specifically mentioned as contraindications or major risk factors.

Q: Can Serpine be used by people with diabetes?

A: Official regulatory documents do not list diabetes as a contraindication. However, as with any systemic medication that affects the circulatory system, its use requires careful clinical assessment and monitoring by a prescribing physician.

Q: Is it possible for Serpine to cause weight gain?

A: Official regulatory documents list sodium and water retention (edema) as a common side effect. This fluid retention can sometimes lead to sudden weight changes. If unexpected changes in body weight are observed, this information is important for the prescribing physician.

Q: How often do people need to have blood tests while taking Serpine?

A: Due to the potential for serious blood disorders, specific monitoring is required during prolonged Serpine therapy. Specific tests, including complete blood counts, are indicated before starting treatment and then periodically during continuous use.

Q: Is Serpine a controlled substance?

A: No, Serpine (Hydralazine) is not classified as a controlled substance and does not fall under the strict regulations of the U.S. Controlled Substances Act (CSA). It is a standard prescription-only medicine.

Q: Why is Serpine prescribed instead of other medications sometimes?

A: Serpine has a distinct mechanism as a direct-acting peripheral vasodilator, meaning it works by relaxing the small blood vessels. This specific action may be an option when managing a patient's Systemic Vascular Resistance (SVR), or when other antihypertensive agents are not suitable.

Q: Does Serpine change how other medications are absorbed in the body?

A: Official regulatory documents note that Serpine can influence the systemic exposure of other drugs. Specifically, it can increase the bioavailability (drug availability) of certain co-administered medicines, such as some beta-blockers.

Q: What happens if you suddenly stop taking Serpine?

A: Sudden discontinuation of Serpine after long-term use is generally not recommended per regulatory guidance. The dose is typically gradually reduced over a period of time to avoid potential adverse reactions, such as rebound hypertension.

Q: Is Serpine commonly used in combination with other drugs?

A: Yes, official prescribing information confirms that Serpine is often used as part of combination therapy. It is commonly prescribed alongside other medicines, such as a beta-blocker and/or a diuretic, to help manage the body's natural compensatory responses to vasodilation.

Q: Will taking Serpine affect my mood or personality?

A: Official regulatory information lists effects on mental state as less common side effects. These can include feelings of anxiety or mental depression. In rare instances, severe mental changes, such as hallucinations, have been reported.

Q: How is the effectiveness of Serpine monitored by a doctor?

A: Regulatory documents indicate that effectiveness and safety are typically monitored by checking the patient’s blood pressure and pulse rate. This is done alongside periodic monitoring through blood tests, as required by official warnings.

Q: Do you need a special prescription for Serpine?

A: No, Serpine is a standard prescription-only medicine. While it requires a physician's prescription, it does not require a special prescribing protocol beyond a standard medical prescription.

Q: Does Serpine cause any issues with vision?

A: Yes, official safety information indicates that Serpine can cause effects related to vision. Blurred vision and other vision changes are listed among the drug's less common reported side effects.

Q: Why do doctors often start Serpine at a low dose?

A: Treatment is initiated with a low dose followed by a stepwise titration. This protocol is designed to minimize common side effects, such as headaches and a rapid heart rate, which are often reported at the start of therapy.

Q: Is there a maximum duration for Serpine treatment?

A: There is no definitive maximum time limit stated in official documents for continuous treatment. However, regulatory warnings stress that the serious risk of developing a Systemic Lupus Erythematosus-like syndrome is linked to prolonged exposure, typically observed after six months.

Q: What does the latest scientific literature say about Serpine's long-term safety?

A: Official product information, based on clinical data, details the risk of a severe immune-related reaction—the SLE-like syndrome—linked to prolonged exposure, typically after six months. This risk factor is key to long-term safety considerations.

Q: Is Serpine available as a generic version?

A: The active ingredient in Serpine is Hydralazine hydrochloride. Hydralazine is widely available under its generic name, as noted in official drug information sources.

Q: Are there any reported interactions between Serpine and common supplements like Vitamin D or magnesium?

A: Official drug interaction lists are primarily focused on prescription medications, food, and alcohol. There is no specific regulatory information detailing interactions with common over-the-counter supplements like Vitamin D or magnesium.

Q: How does Serpine impact blood pressure?

A: Serpine's mechanism of action is to directly relax the muscle cells in the small resistance blood vessels (arterioles). This action reduces the Systemic Vascular Resistance (SVR)—the impedance to blood flow—which leads directly to the primary therapeutic goal of lowering blood pressure.

Q: Are there any genetic factors that influence how Serpine works?

A: Yes, official regulatory documents note that the metabolism of Serpine is subject to polymorphic acetylation, which is influenced by a person's genetics. Individuals classified as slow acetylators generally metabolize the drug more slowly, leading to higher plasma concentrations of Serpine in the body.

Q: Is Serpine safe for people with a history of kidney problems?

A: Serpine may be used in people with renal impairment (kidney problems). Official regulatory documents state that the dose or dosing interval must be adapted to prevent drug accumulation.

How should Serpine be stored and disposed of?

How to Store Serpine

Serpine (Hydralazine) must be stored at Controlled Room Temperature, officially defined as 20 C to 25 C (68 F to 77 F). The regulatory labeling mandates that the medicine be kept in its original container and that the container be tightly closed to ensure stability.

Protection from moisture and light is required. The product must be stored in a dry environment and should not be stored in high-humidity areas, such as a bathroom. It is required to keep this and all medicines out of the sight and reach of children.

Official Disposal Instructions

The preferred method for discarding unused or expired Serpine is to utilize a local drug take-back program or medicine disposal event. If such options are unavailable, regulatory guidance permits mixing the tablets with an undesirable substance, sealing the mixture in a container, and disposing of it in the household trash. The tablets must not be flushed down a toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Serpine found in:

A-Z Index: